Skip to content
Screener

LivaNova LIVN Other Income (Expense)

Other Income (Expense) at other companies

Abbott logo
AbbottABT
$134M-2.2%
Haemonetics logo
HaemoneticsHAE
-$9.88M-13.6%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$165K-101%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-$226K-104%
Medtronic logo
MedtronicMDT
$137M
ITG
Integer HoldingsITGR
-$316K+99.3%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating income49,48454,18390,955102,800
SNIA environmental liability expense(1,677)(362,070)
Interest expense(7,176)(14,931)(15,467)(30,217)
Foreign exchange and other income/(expense)(23,829)(4,255)(29,524)7,161
Income (loss) before income tax18,47933,32045,964(282,326)
Income tax (benefit) expense(90,204)6,151(85,864)17,807
Loss from equity method investments(114)(8)(965)(28)
Net income (loss)$108,569$27,161$130,863$(300,161)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's other income (expense)?
LivaNova (LIVN) reported other income (expense) of -$23.83M in Q2 2026.
How has LivaNova's other income (expense) changed year-over-year?
LivaNova's other income (expense) decreased by 460.0% year-over-year, from -$4.26M to -$23.83M.
What is the long-term trend for LivaNova's other income (expense)?
Over 3 years (2022 to 2025), LivaNova's other income (expense) has grown at a 57.1% compound annual growth rate (CAGR), from $691K to -$2.68M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about LivaNova's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude